Literature DB >> 26578812

Advanced neuroendocrine prostate tumors regress to stemness.

Leigh Ellis1, Massimo Loda2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26578812      PMCID: PMC4664372          DOI: 10.1073/pnas.1519151112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.

Authors:  Zongxiang Zhou; Andrea Flesken-Nikitin; David C Corney; Wei Wang; David W Goodrich; Pradip Roy-Burman; Alexander Yu Nikitin
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

2.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Hao Wang; Brandon Luber; Mary Nakazawa; Jeffrey C Roeser; Yan Chen; Tabrez A Mohammad; Yidong Chen; Helen L Fedor; Tamara L Lotan; Qizhi Zheng; Angelo M De Marzo; John T Isaacs; William B Isaacs; Rosa Nadal; Channing J Paller; Samuel R Denmeade; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  N Engl J Med       Date:  2014-09-03       Impact factor: 91.245

3.  Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.

Authors:  Michael S Kareta; Laura L Gorges; Sana Hafeez; Bérénice A Benayoun; Samuele Marro; Anne-Flore Zmoos; Matthew J Cecchini; Damek Spacek; Luis F Z Batista; Megan O'Brien; Yi-Han Ng; Cheen Euong Ang; Dedeepya Vaka; Steven E Artandi; Frederick A Dick; Anne Brunet; Julien Sage; Marius Wernig
Journal:  Cell Stem Cell       Date:  2014-11-13       Impact factor: 24.633

Review 4.  Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes.

Authors:  Rahul Aggarwal; Tian Zhang; Eric J Small; Andrew J Armstrong
Journal:  J Natl Compr Canc Netw       Date:  2014-05       Impact factor: 11.908

5.  Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.

Authors:  J Wang; J Kim; M Roh; O E Franco; S W Hayward; M L Wills; S A Abdulkadir
Journal:  Oncogene       Date:  2010-02-08       Impact factor: 9.867

6.  Does the microenvironment influence the cell types of origin for prostate cancer?

Authors:  Andrew S Goldstein; Owen N Witte
Journal:  Genes Dev       Date:  2013-07-15       Impact factor: 11.361

Review 7.  Aggressive variants of castration-resistant prostate cancer.

Authors:  Himisha Beltran; Scott Tomlins; Ana Aparicio; Vivek Arora; David Rickman; Gustavo Ayala; Jiaoti Huang; Lawrence True; Martin E Gleave; Howard Soule; Christopher Logothetis; Mark A Rubin
Journal:  Clin Cancer Res       Date:  2014-04-11       Impact factor: 12.531

8.  Polycomb-mediated silencing in neuroendocrine prostate cancer.

Authors:  Pier-Luc Clermont; Dong Lin; Francesco Crea; Rebecca Wu; Hui Xue; Yuwei Wang; Kelsie L Thu; Wan L Lam; Colin C Collins; Yuzhuo Wang; Cheryl D Helgason
Journal:  Clin Epigenetics       Date:  2015-04-03       Impact factor: 6.551

9.  Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.

Authors:  Anastasia Wyce; Yan Degenhardt; Yuchen Bai; BaoChau Le; Susan Korenchuk; Ming-Chih Crouthame; Charles F McHugh; Robert Vessella; Caretha L Creasy; Peter J Tummino; Olena Barbash
Journal:  Oncotarget       Date:  2013-12

10.  Targeting cell cycle and hormone receptor pathways in cancer.

Authors:  C E S Comstock; M A Augello; J F Goodwin; R de Leeuw; M J Schiewer; W F Ostrander; R A Burkhart; A K McClendon; P A McCue; E J Trabulsi; C D Lallas; L G Gomella; M M Centenera; J R Brody; L M Butler; W D Tilley; K E Knudsen
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

View more
  6 in total

1.  Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors.

Authors:  Caroline Xue; Eva Corey; Taranjit S Gujral
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.575

2.  ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.

Authors:  Shaghayegh Nouruzi; Dwaipayan Ganguli; Nakisa Tabrizian; Maxim Kobelev; Olena Sivak; Takeshi Namekawa; Daksh Thaper; Sylvan C Baca; Matthew L Freedman; Adeleke Aguda; Alastair Davies; Amina Zoubeidi
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

3.  TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.

Authors:  David P Labbé; Christopher J Sweeney; Myles Brown; Phillip Galbo; Spencer Rosario; Kristine M Wadosky; Sheng-Yu Ku; Martin Sjöström; Mohammed Alshalalfa; Nicholas Erho; Elai Davicioni; R Jeffrey Karnes; Edward M Schaeffer; Robert B Jenkins; Robert B Den; Ashley E Ross; Michaela Bowden; Ying Huang; Kathryn P Gray; Felix Y Feng; Daniel E Spratt; David W Goodrich; Kevin H Eng; Leigh Ellis
Journal:  Clin Cancer Res       Date:  2017-09-12       Impact factor: 12.531

4.  REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.

Authors:  Yi-Ting Chang; Tzu-Ping Lin; Mel Campbell; Chin-Chen Pan; Shu-Hui Lee; Hsin-Chen Lee; Muh-Hwa Yang; Hsing-Jien Kung; Pei-Ching Chang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

5.  Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.

Authors:  Hannah N W Weinstein; Paul Allegakoen; Marc H Wadsworth; Hanbing Song; Jamie Xie; Heiko Yang; Ethan A Castro; Kevin L Lu; Bradley A Stohr; Felix Y Feng; Peter R Carroll; Bruce Wang; Matthew R Cooperberg; Alex K Shalek; Franklin W Huang
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

6.  ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.

Authors:  Wookbong Kwon; Seong-Kyoon Choi; Daehwan Kim; Hyeon-Gyeom Kim; Jin-Kyu Park; Jee Eun Han; Gil-Jae Cho; Sungho Yun; Wookyung Yu; Se-Hyeon Han; Yun-Sok Ha; Jun Nyung Lee; Tae Gyun Kwon; Dong-Hyung Cho; Jun-Koo Yi; Myoung Ok Kim; Zae Young Ryoo; Song Park
Journal:  J Exp Clin Cancer Res       Date:  2021-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.